Advancements in precision medicine and genetic research are transforming healthcare by enabling personalized treatment plans. Similarly, in psychology, new therapeutic techniques like cognitive-behavioral interventions are effectively addressing mental health challenges. These innovations, supported by technology and interdisciplinary collaboration, are revolutionizing traditional healthcare methods [1-6]. Artificial intelligence plays a transformative role in healthcare by enhancing diagnostic accuracy, optimizing treatment protocols, and improving patient care outcomes [7]. Research into gene expression offers valuable insights into understanding disease mechanisms and potential therapeutic targets [8]. Cancer remains one of the most complex and formidable challenges in healthcare, affecting millions worldwide with a diverse array of tumor types and clinical presentations [9]. Cancer represents the most significant public health issue of the 21st century, as the majority of diagnoses occur at later stages [10]. Biomarkers are essential for enhancing the diagnosis, monitoring, and treatment strategies for cancer [11]. Advancements in understanding the molecular mechanisms of cancer, such as the downregulation of specific genes like LPAR1, are crucial for developing targeted therapies that can potentially inhibit tumor progression and metastasis [12]. In recent decades, the field of oncology has undergone revolutionary changes, spurred by breakthroughs in biomedical research and a burgeoning understanding of cancer’s genetic and molecular landscapes [13, 14]. These advancements have not only transformed diagnostic and prognostic processes but have also reshaped the therapeutic strategies at the disposal of oncologists [15, 16]. The contemporary approach to cancer management is increasingly characterized by its multidisciplinary nature, integrating medical, surgical, and radiation oncology to formulate personalized treatment plans [17]. For instance, effective pharmaceutical management can ensure access to essential medications during health crises like the COVID-19 pandemic, preventing potential shortages [18]. Another example, nurses effectively managed ethical challenges during the COVID-19 pandemic through proficient therapeutic management [19]. Timely interventions, like early cochlear implantation, play a crucial role in optimizing developmental outcomes for children with hearing impairments, underscoring the importance of managing intervention schedules effectively [20]. In managing health conditions like non-alcoholic fatty liver, it is crucial to assess the impact of treatments such as synbiotics on various clinical markers including liver enzymes, obesity, blood pressure, and inflammation [21]. This integration facilitates a comprehensive treatment modality that addresses the multifaceted needs of cancer patients, ensuring that therapeutic decisions are informed by a collaborative team of specialists [22]. Each discipline brings distinct perspectives and expertise, allowing for refined treatment precision, optimized dosing schedules, and minimized adverse effects, all geared toward enhancing patient outcomes and survival rates [23, 24]. Central to the evolution of cancer treatment are targeted therapies and immunotherapies, which represent a shift towards precision medicine [25]. Targeted therapies, such as small molecule inhibitors and monoclonal antibodies, disrupt specific cancer pathways and mechanisms identified through genomic profiling, offering a high degree of specificity and fewer side effects than conventional chemotherapies [26]. Similarly, immunotherapies that modulate the immune system to recognize and combat cancer cells have shown promise in treating previously intractable malignancies, heralding a new era in oncology [27, 28]. However, the transition to these advanced therapies is accompanied by significant challenges. Resistance to therapies has emerged as a critical hurdle, with tumors often developing mechanisms to evade targeted treatments [29, 30]. This issue underscores the need for ongoing research into combination therapies and novel agents that can overcome resistance [31, 32]. Furthermore, the high cost of new treatments and the technological demands of precision medicine pose substantial barriers to access, particularly in low-resource settings [33]. Addressing these disparities is crucial for the equitable distribution of the latest advancements in cancer care [34]. Moreover, as we navigate through these transformative times, the role of genomics and precision medicine continues to expand, promising even more personalized and effective treatment strategies [35, 36]. The integration of big data and machine learning in oncology not only enhances our understanding of tumor biology but also improves our predictive capabilities, leading to better patient stratification and treatment customization [37, 38]. Technology and medical advancements have revolutionized disease management, enabling more accurate diagnostics, effective treatments, and tailored preventive measures to significantly improve patient outcomes and public health [39-42].
To capture the most recent and relevant advancements in cancer treatment, a comprehensive search was conducted across several databases including PubMed, Scopus, and Web of Science. The search criteria focused on studies published in the last fifteen years. Both primary research articles and review papers were considered to ensure a thorough analysis of emerging trends and technologies.
Cancer is a complex disease requiring a multifaceted approach to management and care. Multidisciplinary treatment teams bring together healthcare professionals from diverse specialties to collaboratively evaluate, plan, and implement comprehensive care strategies tailored to the unique needs of each patient. This collaborative model is essential for addressing the multifactorial nature of cancer, which often demands the integration of medical, surgical, and supportive interventions to achieve optimal outcomes [43-47].
Oncologists serve as the central coordinators in the care of cancer patients, making crucial decisions about the primary treatment approach based on the cancer type, stage, and molecular characteristics [48]. They determine whether chemotherapy, immunotherapy, targeted therapy, or hormonal therapy is the most appropriate choice [49]. For example, in HER2-positive breast cancer, oncologists often prioritize targeted therapy with trastuzumab (Herceptin) combined with chemotherapy, a proven strategy that improves survival rates by targeting the HER2 receptor, which is overexpressed in this type of cancer [50]. Oncologists also monitor the patient’s progress throughout treatment, adjusting therapy as needed based on response and side effects [51].
Surgeons are responsible for the physical removal of tumors when surgery is a viable option [52]. Their role is critical in both curative and palliative care [53]. In curative cases, such as colorectal cancer, a surgeon may perform a resection of the affected bowel segment along with the surrounding lymph nodes to ensure complete tumor removal [54]. In cases where cancer cannot be cured, surgeons provide palliative interventions, such as stent placements or bypass procedures, to alleviate symptoms and improve the patient’s quality of life [55]. Surgeons collaborate closely with oncologists and radiotherapists to determine the timing of surgery in relation to chemotherapy, radiation, or other treatments [56].
Radiotherapy specialists design and deliver radiation treatments to target and destroy cancer cells, either post-surgically or as the primary treatment option in certain cancers [57]. Radiation therapy can be used to shrink tumors preoperatively, making them easier to remove or more manageable [58]. For example, in head and neck cancers, radiotherapy is often combined with chemotherapy (chemoradiation) to achieve locoregional control, meaning the treatment helps to shrink the tumor and prevent the spread of cancer cells, while minimizing damage to critical structures such as the vocal cords and swallowing mechanisms [59]. Radiotherapy specialists use advanced imaging techniques to precisely target tumors, ensuring that the surrounding healthy tissues are spared as much as possible [60].
Oncology nurses are integral members of the cancer care team, providing hands-on care and ongoing support throughout the treatment process [61]. They administer chemotherapy, manage side effects, and ensure that patients are comfortable during their treatment regimens [62]. Nurses are responsible for educating patients about their diagnosis, treatment options, potential side effects, and strategies to cope with them [63]. In more specialized cases, such as patients undergoing bone marrow transplants, oncology nurses monitor for complications like graft-versus-host disease (GVHD) and manage post-transplant recovery [64]. They also provide emotional support to patients and families, helping them navigate the challenging aspects of cancer treatment [65].
Support specialists, including psychologists, dietitians, physical therapists, and social workers, are essential in addressing the comprehensive needs of cancer patients [66]. They focus not just on the disease itself, but on the patient’s overall well-being, helping to manage the physical, emotional, and social impacts of cancer [67]. Dietitians, for example, play a key role in developing nutritional plans to combat issues like weight loss or cachexia in patients undergoing chemotherapy, ensuring they maintain strength and avoid malnutrition [68]. Psychologists offer vital support by providing coping strategies for dealing with anxiety, depression, and the emotional toll of a cancer diagnosis [69]. Physical therapists help patients regain strength, mobility, and function, particularly after surgery or in cases of cancer-related fatigue [70]. Social workers assist with navigating the complex healthcare system, providing support with insurance issues, financial concerns, and connecting patients with community resources [71].
By working together, these core team members create a cohesive, patient-centered care plan that integrates the expertise of each specialist. This collaborative approach ensures that patients receive the most effective and comprehensive treatment possible, addressing not just the cancer, but the broader challenges that come with battling such a complex disease.
Effective coordination and collaboration among healthcare professionals are the foundation of high-quality cancer care [44]. Multidisciplinary teams, composed of specialists from diverse medical fields, ensure that every aspect of a patient’s diagnosis and treatment is considered [43]. Regular tumor board meetings and case conferences are key platforms for fostering this collaboration, allowing the team to align their approaches, share expertise, and make decisions that are evidence-based and tailored to the individual needs of each patient [72]. These forums not only streamline care delivery but also improve patient outcomes and satisfaction by fostering a unified approach [73].
Tumor board meetings provide an opportunity for the entire team to review each patient’s case in detail, considering imaging results, biopsy findings, molecular markers, and clinical history [74]. This holistic analysis ensures that treatment decisions are well-informed and scientifically grounded [75]. In a case of non-small cell lung cancer (NSCLC), the team might evaluate genetic testing results, such as EGFR or ALK mutations, alongside imaging studies to determine the best course of action [76]. If the patient has an EGFR mutation, the team may prioritize targeted therapy with an EGFR inhibitor like osimertinib over traditional chemotherapy [77]. For early-stage disease, surgery might be recommended, with adjuvant therapies considered based on the pathology results [78].
Collaboration within the team also supports shared decision-making, where patient preferences and values are integral to the treatment plan [79]. This approach ensures that the care aligns not only with clinical guidelines but also with the patient’s life circumstances and goals [80]. For a patient with localized prostate cancer, the team might present multiple treatment options, such as radical prostatectomy, active surveillance, or radiotherapy [81]. By discussing the patient’s age, overall health, potential side effects, and personal preferences, the team can recommend a tailored plan [82]. For an older patient with comorbidities, active surveillance might be the preferred choice to avoid unnecessary interventions [83].
Cancer treatment often involves complex regimens that can lead to complications or adverse effects, requiring immediate adjustments to the care plan [84]. Multidisciplinary collaboration allows for real-time problem solving, leveraging the collective expertise of the team to address challenges effectively [73]. If a breast cancer patient receiving doxorubicin develops cardiotoxicity, the oncologist may consult a cardiologist to assess the severity of the condition [85]. Based on the cardiologist’s input, the team might decide to discontinue doxorubicin and replace it with a less cardiotoxic agent, such as liposomal doxorubicin or an alternative chemotherapy drug, while implementing measures to protect cardiac function [86, 87].
Beyond disease-focused treatments, cancer care must address the physical, emotional, and psychosocial needs of patients [88]. Holistic management ensures that patients receive comprehensive support, enabling them to endure and benefit from rigorous treatment regimens [89]. A patient undergoing aggressive chemotherapy for acute myeloid leukemia (AML) may experience severe nausea, fatigue, and psychological distress [90]. The multidisciplinary team might include a palliative care specialist to provide symptom relief, a dietitian to ensure proper nutrition despite treatment side effects, and a psychologist to offer emotional support [91]. These interventions enhance the patient’s quality of life and increase the likelihood of completing the prescribed treatment [92].
While innovations such as targeted therapies, immunotherapies, and precision medicine have significantly advanced the precision and effectiveness of cancer treatments, they also bring substantial challenges [93]. These include resistance to therapies, uneven healthcare access, and the high costs associated with new technologies [94]. To address these issues, the implementation of multidisciplinary care has proven crucial [73]. For instance, oncologists work alongside molecular biologists to identify genetic mutations that may predict response or resistance to specific treatments, allowing for more tailored therapy choices [95]. Pharmacists are integral in managing complex drug regimens, especially when patients face side effects that require adjustments in dosage or treatment protocols [96].Genetic counselors play a vital role by helping patients understand their genetic testing results and the implications for their treatment options, which is essential in the context of precision medicine [97]. Furthermore, nurse coordinators facilitate this complex care by ensuring seamless communication among various specialists and between the care team and the patient, aiding in adherence to prescribed therapies and scheduling regular follow-up assessments [67]. Social workers also contribute by helping patients navigate the healthcare system, addressing financial and psychosocial barriers to access, which is particularly important given the economic burdens of new cancer treatments [98].
To enhance the effectiveness of these sophisticated therapies through coordinated efforts, we propose several strategies:
Establishing Integrated Care Pathways: Develop clear protocols that define the roles of each specialist within the care pathway, from diagnosis through to treatment and follow-up, ensuring that all aspects of the patient’s health and well-being are addressed [73]. A 58-year-old patient diagnosed with stage III colon cancer was treated under a newly established integrated care pathway [99]. The pathway involved oncologists, surgeons, dietitians, and physical therapists working in concert [100]. Regular multidisciplinary team meetings ensured that each phase of treatment from surgery to chemotherapy and rehabilitation was tailored and adjusted based on the patient’s recovery progress [101]. This coordinated approach helped the patient manage side effects better and improved the overall treatment adherence and outcomes [102].
Training and Education Programs: Implement ongoing training for healthcare providers to keep abreast of the latest developments in cancer treatment and care management, ensuring that the entire team is equipped to handle complex cases effectively [103]. A children’s hospital introduced an advanced training program focusing on the latest immunotherapies for pediatric leukemia [104]. The case involves a 7-year-old patient whose treatment plan was adjusted after a pediatric oncologist attended a specialized training session on CAR-T cell therapy [105]. The education program enabled the oncologist to implement this cutting-edge treatment effectively, leading to a significant remission in the patient previously unresponsive to traditional therapies [106].
Technology-Enabled Coordination: Utilize digital health technologies to enhance communication and coordination among the multidisciplinary team [107]. This can include shared electronic health records, telehealth services for remote consultations, and mobile apps for monitoring patient health and treatment adherence [108]. A breast cancer patient was managed using a digital health platform that allowed for real-time updates of her treatment progress to all members of her care team, including her oncologist, radiologist, and nurse coordinator [109]. This technology facilitated immediate adjustments to her therapy regime when she developed resistance to a standard drug [110]. The platform also supported telehealth consultations, minimizing her visits to the clinic and optimizing her care schedule without disrupting her treatment efficacy [111].
Patient-Centered Care Models: Focus on personalized care models that consider the patient’s preferences, lifestyle, and socioeconomic status, alongside their clinical needs [112]. A 65-year-old lung cancer patient with a low socioeconomic background was treated under a patient-centered care model [113]. This approach included not only personalized medical treatment but also social work support to address her financial and transportation challenges [114]. The social worker helped the patient receive treatment subsidies and arranged transportation for her clinic visits, ensuring that her health care needs were met comprehensively, which was crucial for her continued participation in a potentially life-saving clinical trial [115]. Policy Advocacy and Funding: Advocate for policies that improve access to new therapies and reduce financial burdens on patients [116]. This includes working with insurance companies and governments to ensure that the costs of innovative cancer treatments are covered, making these advancements accessible to a broader range of patients [117]. An advanced melanoma patient benefited from a new policy advocated by his care team, which involved collaboration between healthcare providers and a pharmaceutical company [118]. The policy provided funding for innovative immunotherapies that were previously unaffordable [119]. As a result, the patient was able to access a pioneering immunotherapy drug, leading to a dramatic improvement in his condition that was not achievable with traditional treatments [120].
Through these strategies, multidisciplinary teams can not only enhance therapeutic outcomes but also improve patient experiences by providing comprehensive support and personalized care, thereby overcoming some of the major challenges faced in modern oncology.
Recent advancements in cancer treatment have revolutionized the field by introducing innovative therapies and improving patient outcomes.
Targeted Therapies and Precision Medicine: The advent of targeted therapies and precision medicine has allowed oncologists to tailor treatments based on the genetic and molecular profiles of tumors. Drugs like osimertinib for EGFR-mutated non-small cell lung cancer and trastuzumab for HER2-positive breast cancer exemplify how these approaches have enhanced survival rates [93].
Immunotherapies: Immunotherapies such as immune checkpoint inhibitors (e.g., pembrolizumab, nivolumab) and CAR-T cell therapies have transformed the treatment landscape for cancers like melanoma and hematologic malignancies [121].
Digital Health Integration: Digital platforms enabling real-time patient monitoring, telehealth consultations, and shared electronic health records have improved multidisciplinary collaboration and patient management [122].
Patient-Centered Care Models: Holistic and patient-centered care approaches addressing physical, emotional, and financial burdens have become integral. Multidisciplinary teams including social workers, dietitians, and genetic counselors enhance the quality of care and adherence to treatment [73].
Despite the significant advancements in cancer treatment, numerous challenges persist, which underscore the need for ongoing research to further optimize cancer management. One critical area is overcoming therapy resistance. Continued studies are required to better understand the mechanisms behind resistance to targeted therapies and immunotherapies, with a focus on developing novel agents or combination strategies that can counteract these barriers. Additionally, while new treatments have proven effective, the high costs associated with cutting-edge therapies remain a pressing issue. Research into more affordable innovations, such as biosimilars and outcome-based pricing models, can help alleviate financial toxicity for patients, making life-saving therapies more accessible. Equally important is addressing the disparities in access to cancer care. Investigations should prioritize strategies to reduce healthcare inequalities, especially for low-income and underserved populations, ensuring that all patients have equitable access to the latest treatments. Furthermore, the integration of artificial intelligence and machine learning in cancer care holds great promise. AI can enhance predictive modeling, optimize treatment planning, and facilitate real-time monitoring, all of which contribute to a more personalized approach and improved outcomes. Finally, psycho-oncology continues to be an essential area of research, with a focus on understanding and addressing the psychosocial impacts of cancer. Research into the effectiveness of interventions aimed at improving mental health and quality of life for patients is critical for ensuring comprehensive care that goes beyond physical treatment. These areas of research represent the next frontier in cancer management, offering hope for better, more inclusive, and effective treatment options for patients worldwide [123-128].
In conclusion, various diseases, ranging from chronic infections to rare disorders, have raised significant concerns in society, deeply impacting individuals’ physical health. These diseases not only disrupt the physical functioning of the body but also challenge individuals’ overall well- being. In this regard, modern technologies in laboratories and research centers play a critical role. Advanced tools and techniques such as high-resolution imaging, genomics, nanotechnology, and artificial intelligence algorithms have enabled more accurate and faster disease diagnoses. These technologies allow researchers to examine molecular and cellular structures in detail and identify patterns of disease manifestation. Furthermore, the development of nanotechnologies and tissue engineering systems has led to the creation of laboratory environments that simulate real body conditions. These environments enable the testing and evaluation of various drugs and treatment methods under conditions closely resembling the physiological environment. As a result, more targeted treatments with fewer side effects can be provided. Consequently, the integration of advanced technologies with interdisciplinary approaches has opened new horizons in disease prevention, diagnosis, and treatment. These achievements not only improve treatment outcomes and enhance patients’ quality of life but also pave the way for the development of personalized and more effective therapies to address the health challenges of today [129- 144]. In recent years, technological advancements have significantly transformed various fields, particularly healthcare and medical research. One of the most notable innovations is the integration of artificial intelligence (AI) with blockchain technology in healthcare supply chains. This integration enhances transparency, efficiency, and decision-making processes in managing healthcare resources, as demonstrated in a study that evaluated and prioritized AI-integrated blockchain factors in healthcare supply chains [145]. Another remarkable development is in the area of medical imaging, where AI-driven models, such as the combination of U-Net and ResNet50 architectures, have been applied for the detection of brain cancer through MRI scans. This approach improves the accuracy and reliability of early cancer detection, offering better outcomes for patients [146]. Additionally, the field of regenerative medicine has seen significant advancements, particularly in the treatment of periodontitis. A systematic review and meta-analysis on the effectiveness and stability of regenerative treatments combined with orthodontic tooth movement for Stage IV periodontitis highlighted the promising results of these new approaches in dental care [147]. Similarly, the use of nanoparticles, such as chitosan and titanium dioxide mixed with orthodontic primers, has been evaluated for its effect on shear bond strength, further improving the effectiveness of dental treatments. These innovations reflect the ongoing evolution of technologies in the medical and healthcare industries, making treatments more efficient and precise [148]. Another example in management is the importance of identifying pollutants and drug resistance to improve public health policies. This research can provide valuable insights into how pollutants are dispersed and their impacts on community health. A better understanding of the dissemination process can pave the way for developing policies and preventive measures to mitigate adverse environmental effects. Additionally, considering global challenges such as drug resistance, identifying the mechanisms behind antibiotic resistance can contribute to devising strategies to safeguard public health. Overall, the findings of this study could serve as a valuable resource in enhancing health programs and designing preventive strategies aimed at improving community well-being [149-150]. Cancer treatment has experienced groundbreaking advancements, Paper-based sensors offer rapid, cost-effective, and accurate cancer marker detection [151], while advancements in precision medicine, immunotherapy, and integrative care have significantly improved survival rates and quality of life [152].
However, challenges such as therapy resistance, financial toxicity, and inequities in access to care remain. Multidisciplinary treatment teams, which are the cornerstone of modern cancer care, play a crucial role in overcoming these barriers by delivering comprehensive, patient-centered care. These teams, which involve diverse specialists such as oncologists, pharmacists, genetic counselors, and social workers, enhance clinical outcomes, ensure holistic care, and improve patient satisfaction. The future of cancer management relies on fostering interdisciplinary collaboration, integrating cutting-edge technologies, and ensuring that high-quality, equitable care is accessible to all patients. Addressing these challenges through continued innovation, team dynamics refinement, and policy advocacy will enable the oncology field to further reduce the global burden of cancer and improve patient outcomes across diverse populations.
• Author declares no conflict of interest
• Study was approved by Research Ethic Committee of author affiliated Institute.
• Study’s data is available upon a reasonable request.
• All authors have contributed to implementation of this research.